company background image
ATORX logo

Alligator Bioscience OM:ATORX Stock Report

Last Price

SEK 0.27

Market Cap

SEK 202.0m

7D

-6.2%

1Y

-62.6%

Updated

20 Dec, 2024

Data

Company Financials +

Alligator Bioscience AB (publ)

OM:ATORX Stock Report

Market Cap: SEK 202.0m

ATORX Stock Overview

A research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Sweden. More details

ATORX fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Alligator Bioscience AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for Alligator Bioscience
Historical stock prices
Current Share PriceSEK 0.27
52 Week HighSEK 1.57
52 Week LowSEK 0.22
Beta1.52
1 Month Change-47.02%
3 Month Change-79.84%
1 Year Change-62.57%
3 Year Change-88.46%
5 Year Change-97.46%
Change since IPO-99.30%

Recent News & Updates

Recent updates

Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

Dec 01
Will Alligator Bioscience (STO:ATORX) Spend Its Cash Wisely?

We're Keeping An Eye On Alligator Bioscience's (STO:ATORX) Cash Burn Rate

Dec 21
We're Keeping An Eye On Alligator Bioscience's (STO:ATORX) Cash Burn Rate

Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Jul 30
Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Jan 06
Is Alligator Bioscience (STO:ATORX) In A Good Position To Invest In Growth?

Here's Why We're Watching Alligator Bioscience's (STO:ATORX) Cash Burn Situation

Aug 18
Here's Why We're Watching Alligator Bioscience's (STO:ATORX) Cash Burn Situation

Shareholder Returns

ATORXSE BiotechsSE Market
7D-6.2%1.1%-3.3%
1Y-62.6%14.6%4.8%

Return vs Industry: ATORX underperformed the Swedish Biotechs industry which returned 14.6% over the past year.

Return vs Market: ATORX underperformed the Swedish Market which returned 4.8% over the past year.

Price Volatility

Is ATORX's price volatile compared to industry and market?
ATORX volatility
ATORX Average Weekly Movement20.8%
Biotechs Industry Average Movement9.9%
Market Average Movement5.6%
10% most volatile stocks in SE Market11.3%
10% least volatile stocks in SE Market3.2%

Stable Share Price: ATORX's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: ATORX's weekly volatility has increased from 15% to 21% over the past year.

About the Company

FoundedEmployeesCEOWebsite
200047Søren Bregenholtwww.alligatorbioscience.se

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Sweden. The company’s product portfolio includes Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 2 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer; and ATOR-4066, tumor-directed bispecific antibody, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage. It also offers ALG

Alligator Bioscience AB (publ) Fundamentals Summary

How do Alligator Bioscience's earnings and revenue compare to its market cap?
ATORX fundamental statistics
Market capSEK 202.02m
Earnings (TTM)-SEK 248.30m
Revenue (TTM)SEK 27.77m

7.3x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ATORX income statement (TTM)
RevenueSEK 27.77m
Cost of RevenueSEK 182.11m
Gross Profit-SEK 154.33m
Other ExpensesSEK 93.97m
Earnings-SEK 248.30m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Jan 22, 2025

Earnings per share (EPS)-0.33
Gross Margin-555.68%
Net Profit Margin-894.02%
Debt/Equity Ratio0%

How did ATORX perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 21:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alligator Bioscience AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ingrid GafanhãoKempen & Co. NV
Carl RamaniusRedeye